HPV
Clinical trials for HPV explained in plain language.
Never miss a new study
Get alerted when new HPV trials appear
Sign up with your email to follow new studies for HPV, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Cancer trial pulled before it started: HPV drug study never enrolled a single patient
Disease control TerminatedThis study was designed for people with HPV-positive oropharyngeal cancer who still had signs of the virus in their blood after finishing standard treatment. The goal was to see if an immunotherapy drug called BALSTILIMAB could clear the virus and improve long-term survival. Howe…
Matched conditions: HPV
Phase: PHASE2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated May 17, 2026 07:39 UTC
-
New Triple-Drug attack aims to shrink Hard-to-Treat cancers
Disease control OngoingThis study tests a combination of three drugs (entinostat, PDS01ADC, and bintrafusp alfa) in adults with advanced cancers linked to HPV or certain colon cancers that haven't responded well to standard treatments. The goal is to find a safe dose and see if the combo can shrink tum…
Matched conditions: HPV
Phase: PHASE1, PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated May 17, 2026 07:34 UTC
-
New combo therapy aims to shrink throat tumors and cut radiation side effects
Disease control OngoingThis study tests whether adding experimental immune-boosting drugs (HB-201 and HB-202) to standard chemotherapy can shrink HPV16-positive throat tumors more effectively. The goal is to reduce the amount of radiation or chemotherapy needed afterward, potentially lowering side effe…
Matched conditions: HPV
Phase: PHASE1, PHASE2 • Sponsor: University of Chicago • Aim: Disease control
Last updated May 11, 2026 20:53 UTC
-
ER visit could include a Life-Saving cancer screening
Diagnosis OngoingThis study looks at whether offering cervical cancer screening in the emergency department can help more people get tested. About 200 women and transgender/non-binary individuals with a cervix, aged 25-65, will be offered screening during their ER visit. Participants will get a f…
Matched conditions: HPV
Phase: NA • Sponsor: University of Rochester • Aim: Diagnosis
Last updated May 17, 2026 07:38 UTC
-
Mail-In HPV test could boost cervical cancer screening in quebec
Diagnosis OngoingThis study looks at whether letting women collect their own samples for HPV testing at home or in community locations can increase cervical cancer screening rates. About 1,000 women in Quebec aged 25-65 will try different ways to get and return a self-sampling kit. The goal is to…
Matched conditions: HPV
Phase: NA • Sponsor: Université de Sherbrooke • Aim: Diagnosis
Last updated May 17, 2026 07:36 UTC
-
Could starting HPV shots at age 9 save more lives? major trial underway
Prevention OngoingThis study looks at whether offering the HPV vaccine to children at age 9 or 10, instead of the usual age of 11 or 12, makes parents more likely to agree to it. The goal is to get more kids fully vaccinated before they are exposed to the virus, which can cause several cancers lat…
Matched conditions: HPV
Phase: NA • Sponsor: University of Colorado, Denver • Aim: Prevention
Last updated May 17, 2026 07:37 UTC
-
Mothers and daughters join forces to fight HPV in nigeria
Prevention OngoingThis study tests a new community-designed campaign to help prevent HPV, a virus that can cause cancer. About 1,838 mother-daughter pairs in Nigeria will take part. The campaign aims to increase HPV vaccination for girls and HPV self-testing for mothers, using ideas crowdsourced f…
Matched conditions: HPV
Phase: NA • Sponsor: Washington University School of Medicine • Aim: Prevention
Last updated May 17, 2026 07:34 UTC
-
School push to boost HPV shots in south african kids
Prevention TerminatedThis study tests a school-based program to help children in South Africa get the HPV vaccine, which prevents cancers caused by HPV. About 600 fifth graders (ages 9-12) and their parents will take part. The program uses communication strategies to encourage vaccine uptake and comp…
Matched conditions: HPV
Phase: NA • Sponsor: Brigham and Women's Hospital • Aim: Prevention
Last updated May 15, 2026 11:56 UTC
-
New study to test HPV vaccine and better screening for women with HIV
Knowledge-focused ENROLLING_BY_INVITATIONThis study looks at how effective the HPV vaccine is in women living with HIV and whether newer screening methods can catch cervical cancer earlier. About 810 women will use a self-sampling kit at home to test for high-risk HPV. Those who test positive will have a clinic visit wi…
Matched conditions: HPV
Sponsor: University of California, Los Angeles • Aim: Knowledge-focused
Last updated May 17, 2026 07:35 UTC
-
Scientists dive deep to unlock HPV Vaccine's lasting power
Knowledge-focused OngoingThis study tracks 17 healthy adults aged 18-45 who receive the standard three-dose HPV vaccine. Researchers collect blood, saliva, lymph node, and bone marrow samples over five years to understand how the body builds and maintains strong antibody defenses. The goal is to learn wh…
Matched conditions: HPV
Phase: PHASE4 • Sponsor: Emory University • Aim: Knowledge-focused
Last updated May 11, 2026 20:38 UTC